Complexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in Tuberculosis

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Da Silva, Marcos Vinicius ^a   Tiburcio, Monique Gomes Salles ^a   Machado, Juliana Reis ^a,b   Silva, Djalma Alexandre Alves ^a   Rodrigues, Denise Bertulucci Rocha ^a,c   Rodrigues, Virmondes ^a   Oliveira, Carlo Jose Freire ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c UNIVERSITY OF UBERABA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HELPER CELL; HUMAN; IMMUNE RESPONSE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLEURA EFFUSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; TH22 CELL; TH9 CELL; TUBERCULOSIS; ANIMAL; IMMUNITY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CYTOKINES; HUMANS; IMMUNITY; INTERLEUKIN-10; MYCOBACTERIUM TUBERCULOSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TUBERCULOSIS;

EID: 84944200303     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/639107     Document Type: Review

References (178)

1. WHO, Global Tuberculosis Report 2013, 2013
2. H. Hartman-Adams, K. Clark, andG. Juckett, "Update on latent tuberculosis infection," American Family Physician, vol. 89, no. 11, pp. 889-896, 2014
3. J. L. Flynn and J. Chan, "Immunology of tuberculosis," Annual Review of Immunology, vol. 19, pp. 93-129, 2001
4. A. M. Caruso,N. Serbina,E. Klein,K. Triebold, B. R. Bloom, and J. L. Flynn, "Mice deficient in CD4 T cells have only transiently diminished levels of IFN-, yet succumb to tuberculosis," Journal of Immunology, vol. 162, no. 9, pp. 5407-5416, 1999
5. T. Mogues, M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North, "The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice,"The Journal of Experimental Medicine, vol. 193, no. 3, pp. 271-280, 2001
6. C. Geldmacher, A. Zumla, and M. Hoelscher, "Interaction between HIV andMycobacterium tuberculosis: HIV-1-induced CD4 T-cell depletion and the development of active tuberculosis," CurrentOpinion in HIV and AIDS, vol. 7, no. 3,pp. 268-275, 2012
7. A. M. Cooper, J. Magram, J. Ferrante, and I. M. Orme, "Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis,"The Journal of ExperimentalMedicine, vol. 186, no. 1, pp. 39-45, 1997
8. J. L. Flynn, J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom, "An essential role for interferon in resistance to Mycobacterium tuberculosis infection," Journal of Experimental Medicine, vol. 178, no. 6, pp. 2249-2254, 1993
9. A. M. Cooper, D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme, "Disseminated tuberculosis in interferon gene-disrupted mice,"The Journal of Experimental Medicine, vol. 178, no. 6, pp. 2243-2247, 1993
10. B. M. Sullivan, O. Jobe, V. Lazarevic et al., "Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFNgamma production," Journal of Immunology, vol. 175, no. 7, pp. 4593-4602, 2005
11. J.-L. Casanova and L. Abel, "Genetic dissection of immunity to mycobacteria: the human model," Annual Review of Immunology, vol. 20, pp. 581-620, 2002
12. S. Ashenafi, G. Aderaye, A. Bekele et al., "Progression of clinical tuberculosis is associated with a Th2 immune response signature in combination with elevated levels of SOCS3," Clinical Immunology, vol. 151, no. 2, pp. 84-99, 2014
13. Y. Lin, M. Zhang, F. M. Hofman, J. Gong, and P. F. Barnes, "Absence of a prominent Th2 cytokine response in human tuberculosis," Infection and Immunity, vol. 64, no. 4, pp. 1351-1356, 1996
14. S. Winkler, M. Necek, H. Winkler et al., "Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa," Microbes and Infection, vol. 7, no. 9-10, pp. 1161-1169, 2005
15. R. Hernández-Pando, H. Orozcoe, A. Sampieri et al., "Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis," Immunology, vol. 89, no. 1, pp. 26-33, 1996
16. J. C. Ferraz, F. B. S. Melo, M. F. P. M. Albuquerque, S. M. L. Montenegro, and F. G. C. Abath, "Immune factors and immunoregulation in tuberculosis," Brazilian Journal ofMedical and Biological Research, vol. 39, no. 11, pp. 1387-1397, 2006
17. N. D. Marin, S. C. París, V. M. Vélez, C. A. Rojas, M. Rojas, and L. F. García, "Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis," Tuberculosis (Edinb), vol. 90, no. 4, pp. 252-261, 2010
18. L. Geffner,N. Yokobori, J. Basile et al., "Patientswithmultidrugresistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains," Infection and Immunity, vol. 77, no. 11, pp. 5025-5034, 2009
19. C. Y. Chen, D. Huang, S. Yao et al., "IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative treg-T effector cooperation in immunity to TB,"The Journal of Immunology, vol. 188, no. 9, pp. 4278-4288, 2012
20. T. J. Scriba, B. Kalsdorf,D.-A. Abrahams et al., "Distinct, specific IL-17-and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response," Journal of Immunology, vol. 180, no. 3, pp. 1962-1970, 2008
21. X. Chen, M. Zhang, M. Liao et al., "Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T cells," American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 7, pp. 734-742, 2010
22. A. Cruz, S. A. Khader, E. Torrado et al., "Cutting edge: IFN- regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection," The Journal of Immunology, vol. 177, no. 3, pp. 1416-1420, 2006
23. A. Cruz, A. G. Fraga, J. J. Fountain et al., "Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis," Journal of Experimental Medicine, vol. 207, no. 8, pp. 1609-1616, 2010
24. S. A. Khader, G. K. Bell, J. E. Pearl et al., "IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge," Nature Immunology, vol. 8, no. 4, pp. 369-377, 2007
25. T. M. Wozniak, B. M. Saunders, A. A. Ryan, and W. J. Britton, "Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon," Infection and Immunity, vol. 78, no. 10, pp. 4187-4194, 2010
26. Y. O. Yoshida, M. Umemura, A. Yahagi et al., "Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung," Journal of Immunology, vol. 184, no. 8, pp. 4414-4422, 2010
27. A. M. Gallegos, J. W. J. van Heijst, M. Samstein, X. Su, E. G. Pamer, and M. S. Glickman, "A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo," PLoS Pathogens, vol. 7, no. 5, Article ID e1002052, 2011
28. Y. Qiu, Y. Huang, J. Chen, D. Qiao, G. Zeng, and J. Cai, "Depletion of IL-22 during culture enhanced antigen-driven IFN-gamma production by CD4+T cells from patients with active TB," Immunology Letters, vol. 150, no. 1-2, pp. 48-53, 2013
29. K. Matthews,K. A. Wilkinson, B. Kalsdorf et al., "Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis," Tuberculosis, vol. 91, no. 6, pp. 587-593, 2011
30. D. Qiao, B. Y. Yang, L. Li et al., "ESAT-6-and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the localimmune response against Mycobacterium tuberculosis infection," Scandinavian Journal of Immunology, vol. 73, no. 4, pp. 330-337, 2011
31. L. Li,D. Qiao,X. Fu, S. Lao, X. Zhang, andC. Wu, "Identification of mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy," PLoS ONE, vol. 6, no. 5,Article ID e20165, 2011
32. J. Behrends, J.-C. Renauld, S. Ehlers, and C. Hölscher, "IL-22 is mainly produced by IFN-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection," PLoS ONE, vol. 8, no. 2,Article ID e57379, 2013
33. M. V. da Silva, A. A. Figueiredo, J. R. Machado et al., "T cell activation and proinflammatory cytokine production in clinically cured tuberculosis are time-dependent and accompanied by upregulation of IL-10," PLoS ONE, vol. 8, no. 6, Article ID e65492, 2013
34. S. K. Schwander, M. Torres, E. Sada et al., "Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis," Journal of Infectious Diseases, vol. 178, no. 5, pp. 1434-1445, 1998
35. J. Nemeth, H.-M. Winkler, R. H. Zwick et al., "Recruitment of mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis," Journal of Internal Medicine, vol. 265, no. 1, pp. 163-168, 2009
36. J. Walrath, L. Zukowski, A. Krywiak, and R. F. Silver, "Resident Th1-like effector memory cells in pulmonary recall responses toMycobacteriumtuberculosis," American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 1, pp. 48-55, 2005
37. T. C. Y. Tsao, C.-C. Huang, W.-K. Chiou, P.-Y. Yang, M.-J. Hsieh, and K.-C. Tsao, "Levels of interferon- And interleukin-2 receptor- for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis," International Journal of Tuberculosis and Lung Disease, vol. 6, no. 8, pp. 720-727, 2002
38. B. Nandi and S. M. Behar, "Regulation of neutrophils by interferon- limits lung inflammation during tuberculosis infection," The Journal of Experimental Medicine, vol. 208, no. 11, pp. 2251-2262, 2011
39. J. Chan, Y. Xing, R. S. Magliozzo, and B. R. Bloom, "Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activatedmurine macrophages,"The Journal of Experimental Medicine, vol. 175, no. 4, pp. 1111-1122, 1992
40. H.-S. S. Choi, P. R. Rai, H. W. Chu, C. Cool, and E. D. Chan, "Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis," The American Journal of Respiratory and Critical Care Medicine, vol. 166, no. 2, pp. 178-186, 2002
41. M. G. Gutierrez, S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic, "Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages," Cell, vol. 119, no. 6, pp. 753-766, 2004
42. J. L. Flynn, M. M. Goldstein, J. Chan et al., "Tumor necrosis factor- is required in the protective immune response against Mycobacteriumtuberculosis in mice," Immunity, vol. 2, no. 6, pp. 561-572, 1995
43. A. G. D. Bean, D. R. Roach, H. Briscoe et al., "Structural deficiencies in granulomaformation in TNFgene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin," Journal of Immunology, vol. 162, no. 6, pp. 3504-3511, 1999
44. V. P. Mohan,C. A. Scanga, K. Yu et al., "Effectsof tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology," Infection and Immunity, vol. 69, no. 3, pp. 1847-1855, 2001
45. M. A. Gardam, E. C. Keystone, R. Menzies et al., "Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management," Lancet Infectious Diseases, vol. 3, no. 3, pp. 148-155, 2003
46. J. Keane, "TNF-blocking agents and tuberculosis: new drugs illuminate an old topic," Rheumatology, vol. 44, no. 6, pp. 714-720, 2005
47. X. Xie, F. Li, J.-W. Chen, and J. Wang, "Risk of tuberculosis infection in anti-TNF- biological therapy: from bench to bedside," Journal of Microbiology, Immunology and Infection, vol. 47, no. 4, pp. 268-274, 2014
48. M. Koga, S. Terawaki, R. Tatsukawa,M. Fujita, S. Imafuku, and J. Nakayama, "Development of miliary tuberculosis related to anti-tumor necrosis factor-alpha inhibitor therapy for pustular psoriasis," The Journal of Dermatology, vol. 40, no. 6, pp. 476-477, 2013
49. H.-M. Surcel, M. Troye-Blomberg, S. Paulie et al., "Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens," Immunology, vol. 81, no. 2, pp. 171-176, 1994
50. G. T. Seah, G. M. Scott, and G. A. W. Rook, "Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis," Journal of Infectious Diseases, vol. 181, no. 1, pp. 385-389, 2000
51. R. Van Crevel, E. Karyadi, F. Preyers et al., "Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities," Journal of Infectious Diseases, vol. 181, no. 3, pp. 1194-1197, 2000
52. D. Dlugovitzky, A. Torres-Morales, L. Rateni et al., "Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement," FEMS Immunology and Medical Microbiology, vol. 18, no. 3, pp. 203-207, 1997
53. G. Mazzarella, A. Bianco, F. Perna et al., "T lymphocyte phenotypic profile in lung segments affected by cavitary and noncavitary tuberculosis," Clinical and Experimental Immunology, vol. 132, no. 2, pp. 283-288, 2003
54. A. D. HowardandB. S. Zwilling, "Reactivationof tuberculosis is associated with a shift from type 1 to type 2 cytokines," Clinical and Experimental Immunology, vol. 115, no. 3,pp. 428-434, 1999
55. K. J. Erb, J. Kirman, B. Delahunt,W. Chen, and G. Le Gros, "IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice," Immunology and Cell Biology, vol. 76, no. 1, pp. 41-46, 1998
56. R. J. North, "Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis," Clinical and Experimental Immunology, vol. 113, no. 1, pp. 55-58, 1998
57. J. Harris, S. A. DeHaro, S. S. Master et al., "T helper 2 cytokines inhibit autophagic control of intracellularMycobacteriumtuberculosis," Immunity, vol. 27, no. 3, pp. 505-517, 2007
58. B. Jamil, F. Shahid, Z. Hasan et al., "Interferon/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis," Tuberculosis, vol. 87, no. 4, pp. 279-287, 2007
59. Z. T. Handzel, V. Barak, Y. Altman et al., "Increased Th1 andTh2 type cytokine production in patients with active tuberculosis," Israel Medical Association Journal, vol. 9, no. 6, pp. 479-483, 2007
60. M. Zhang, Y. Lin, D. V. Iyer, J. Gong, J. S. Abrams, and P. F. Barnes, "T-cell cytokine responses in human infection with Mycobacterium tuberculosis," Infection and Immunity, vol. 63, no. 8, pp. 3231-3234, 1995
61. D. M. Higgins, J. Sanchez-Campillo, A. G. Rosas-Taraco, E. J. Lee, I. M. Orme, and M. Gonzalez-Juarrero, "Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection," Tuberculosis (Edinb), vol. 89, no. 2, pp. 149-157, 2009
62. R. Gopal, Y. Lin, N. Obermajer et al., "IL-23-dependent IL-17 drives Th1-cell responses following Mycobacterium bovis BCG vaccination," European Journal of Immunology, vol. 42,no. 2, pp. 364-373, 2012
63. Z.-J. Ye, M.-L. Yuan, Q. Zhou et al., "Differentiation and recruitment ofTh9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection," PLoS ONE, vol. 7, no. 2, Article IDe31710, 2012
64. V. Staudt, E. Bothur, M. Klein et al., "Interferon-regulatory factor 4 is essential for the developmental program of t helper 9 cells," Immunity, vol. 33, no. 2, pp. 192-202, 2010
65. M. S. Wilson, C. G. Feng, D. L. Barber et al., "Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections," Journal of Immunology, vol. 184, no. 8, pp. 4378-4390, 2010
66. A. A. Chackerian, J. M. Alt, T. V. Perera, C. C. Dascher, and S. M. Behar, "Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity," Infection and Immunity, vol. 70, no. 8, pp. 4501-4509, 2002
67. A. J. Wolf, B. Linas, G. J. Trevejo-Nuñez et al., "Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo," Journal of Immunology, vol. 179, no. 4, pp. 2509-2519, 2007
68. A. O'Garra, P. S. Redford, F. W. McNab, C. I. Bloom, R. J. Wilkinson, and M. P. R. Berry, "The immune response in tuberculosis," Annual Review of Immunology, vol. 31, pp. 475-527, 2013
69. A. M. Green, R. DiFazio, and J. L. Flynn, "IFN- from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection," Journal of Immunology (Baltimore, Md.: 1950), vol. 190, no. 1, pp. 270-277, 2013
70. S. Bhattacharyya, R. Singla, A. B. Dey, and H. K. Prasad, "Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis," Infection and Immunity, vol. 67, no. 11, pp. 5597-5603, 1999
71. J.-S. Lee, C.-H. Song, C.-H. Kim et al., "Profiles of IFN- And its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral bloodmononuclear cells frompatientswithmultidrug-resistant tuberculosis," Clinical&Experimental Immunology, vol. 128, no. 3, pp. 516-524, 2002
72. R. Vankayalapati, B. Wizel, S. E. Weis et al., "Serum cytokine concentrations do not parallel Mycobacterium tuberculosis- induced cytokine production in patients with tuberculosis," Clinical Infectious Diseases, vol. 36, no. 1, pp. 24-28, 2003
73. C. B. Pereira, M. Palaci, O. H. M. Leite, A. J. S. Duarte, and G. Benard, "Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations," Microbes and Infection, vol. 6, no. 1, pp. 25-33, 2004
74. E. Sahiratmadja, B. Alisjahbana, T. de Boer et al., "Dynamic changes in pro-and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment," Infection and Immunity, vol. 75, no. 2, pp. 820-829, 2007
75. R. Al-Attiyah, A. S. Mustafa, A. T. Abal, N. M. Madi, and P. Andersen, "Restoration of mycobacterial antigen-induced proliferation and interferon- responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy," FEMS Immunology & Medical Microbiology, vol. 38, no. 3, pp. 249-256, 2003
76. R. Diel, R. Loddenkemper, S. Niemann, K. Meywald-Walter, and A. Nienhaus, "Negative and positive predictive value of a whole-blood interferon- release assay for developing active tuberculosis: an update," The American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 1, pp. 88-95, 2011
77. C. S. Hirsch, Z. Toossi, C. Othieno et al., "Depressed T-cell interferon- responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy," The Journal of Infectious Diseases, vol. 180, no. 6, pp. 2069-2073, 1999
78. F. Dieli, G. Friscia, C. di Sano et al., "Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy," Journal of Infectious Diseases, vol. 180, no. 1, pp. 225-228, 1999
79. R. J. Wilkinson, H. M. Vordermeier, K. A. Wilkinson et al., "Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy," Journal of Infectious Diseases, vol. 178, no. 3, pp. 760-768, 1998
80. P. F. Barnes, S. D. Mistry, C. L. Cooper, C. Pirmez, T. H. Rea, and R. L. Modlin, "Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis," Journal of Immunology, vol. 142, no. 4, pp. 1114-1119, 1989
81. C. Nunes-Alves, M. G. Booty, S. M. Carpenter, P. Jayaraman, A. C. Rothchild, and S. M. Behar, "In search of a newparadigm for protective immunity to TB," Nature Reviews Microbiology, vol. 12, no. 4, pp. 289-299, 2014
82. J. L. Flynn and J. Chan, "What's good for the host is good for the bug," Trends in Microbiology, vol. 13, no. 3, pp. 98-102, 2005
83. R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer, "Innate immunity to Mycobacterium tuberculosis," Clinical Microbiology Reviews, vol. 15, no. 2, pp. 294-309, 2002
84. A. Marchant,A. Amedei, A. Azzurri et al., "Polarization of PPDspecific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12," The American Journal of Respiratory Cell andMolecular Biology, vol. 24, no. 2, pp. 187-194, 2001
85. S. B. Bradfute, E. F. Castillo, J. Arko-Mensah et al., "Autophagy as an immune effector against tuberculosis," Current Opinion in Microbiology, vol. 16, no. 3, pp. 355-365, 2013
86. J. Harris, S. S. Master, S. A. de Haro et al., "Th1-Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages," Veterinary Immunology and Immunopathology, vol. 128, no. 1&3, pp. 37-43, 2009
87. D. Schmid and C. Münz, "Innate and adaptive immunity through autophagy," Immunity, vol. 27, no. 1, pp. 11-21, 2007
88. G. A. W. Rook, R. Hernandez-Pando, K. Dheda, andG. T. Seah, "IL-4 in tuberculosis: implications for vaccine design," Trends in Immunology, vol. 25, no. 9, pp. 483-488, 2004
89. S. Z. Josefowicz, L.-F. Lu, and A. Y. Rudensky, "Regulatory T cells: mechanisms of differentiation and function," Annual Review of Immunology, vol. 30, pp. 531-564, 2012
90. R. Ribeiro-Rodrigues, T. Resende Co, R. Rojas et al., "A role for CD4+ CD25+ T cells in regulation of the immune response during human tuberculosis," Clinical & Experimental Immunology, vol. 144, no. 1, pp. 25-34, 2006
91. V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani, "Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis," The American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 7, pp. 803-810, 2006
92. K. Ghoreschi, A. Laurence, X.-P. Yang et al., "Generation of pathogenic TH 17 cells in the absence of TGF- 2 signalling," Nature, vol. 467, no. 7318, pp. 967-971, 2010
93. L. Li, S.-H. Lao, and C.-Y. Wu, "Increased frequency of CD4+CD25 Treg cells inhibit BCG-specific induction of IFN- by CD4+ T cells fromTB patients," Tuberculosis, vol. 87, no. 6, pp. 526-534, 2007
94. X. Y. He, L. Xiao, H. B. Chen et al., "T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients," European Journal of Clinical Microbiology and Infectious Diseases, vol. 29, no. 6, pp. 643-650, 2010
95. K. M. Quinn, R. S. McHugh, F. J. Rich et al., "Inactivation of CD4+CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load," Immunology and Cell Biology, vol. 84, no. 5, pp. 467-474, 2006
96. X. P. Yang, K. Ghoreschi, S. M. Steward-Tharp et al., "Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5," Nature Immunology, vol. 12, no. 3, pp. 247-254, 2011
97. Z. Toossi, P. Gogate, H. Shiratsuchi, T. Young, and J. J. Ellner, "Enhanced production of TGF- by blood monocytes from patients with active tuberculosis and presence of TGF- in tuberculous granulomatous lung lesions," Journal of Immunology, vol. 154, no. 1, pp. 465-473, 1995
98. S. A. Khader, J. E. Pearl, K. Sakamoto et al., "IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN- responses if IL-12p70 is available," Journal of Immunology, vol. 175, no. 2, pp. 788-795, 2005
99. T. Lindenstrøm, J. Woodworth, J. Dietrich, C. Aagaard, P. Andersen, and E. M. Agger, "Vaccine-induced Th17 cells are maintained long-term postvaccination as a distinct and phenotypically stablememory subset," Infection and Immunity, vol. 80, no. 10, pp. 3533-3544, 2012
100. C. J. Murray, K. F. Ortblad, C. Guinovart et al., "Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013," The Lancet, vol. 384, no. 9947, pp. 1005-1070, 2013
101. G. F. Sonnenberg, L. A. Fouser, and D. Artis, "Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22," Nature Immunology, vol. 12, no. 5, pp. 383-390, 2011
102. M. Veldhoen, C. Uyttenhove, J. van Snick et al., "Transforming growth factor- 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset," Nature Immunology, vol. 9, no. 12, pp. 1341-1346, 2008
103. Y. Yu, Y. Zhang, S. Hu et al., "Different patterns of cytokines and chemokines combined with IFN- production reflectmycobacterium tuberculosis infection and disease," PLoS ONE, vol. 7, no. 9, Article ID e44944, 2012
104. D. Anbarasu, C. P. Raja, and A. Raja, "Multiplex analysis of cytokines/chemokines as biomarkers that differentiate healthy contacts from tuberculosis patients in high endemic settings," Cytokine, vol. 61, no. 3, pp. 747-754, 2013
105. Y.-G. Hur, A. C. Crampin, C. Chisambo et al., "Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children," Clinical and Vaccine Immunology, vol. 21, no. 2, pp. 133-142, 2014
106. B. Wu, C. Huang, M. Kato-Maeda et al., "IL-9 is associated with an impaired Th1 immune response in patients with tuberculosis," Clinical Immunology, vol. 126, no. 2, pp. 202-210, 2008
107. P. C. Hill, R. H. Brookes, A. Fox et al., "Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from exposure in the Gambia," PLoS ONE, vol. 1, no. 1, article e68, 2006
108. S. Sakaguchi, "Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses," Annual Review of Immunology, vol. 22, pp. 531-562, 2004
109. A. T. Endharti, M. Rifa'I, Z. Shi et al., "Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN- production and proliferation of CD8+ T cells1," Journal of Immunology, vol. 175, no. 11, pp. 7093-7097, 2005
110. A. O'Garra and P. Vieira, "TH1 cells control themselves by producing interleukin-10," Nature Reviews Immunology, vol. 7, no. 6, pp. 425-428, 2007
111. J. Zhu, H. Yamane, and W. E. Paul, "Differentiation of effector CD4 T cell populations," Annual Review of Immunology, vol. 28, pp. 445-489, 2010
112. M. J. McGeachy,K. S. Bak-Jensen,Y. Chen et al., "TGF- And IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology," Nature Immunology, vol. 8, no. 12, pp. 1390-1397, 2007
113. V. Dardalhon, A. Awasthi, H. Kwon et al., "IL-4 inhibits TGF-induced Foxp3+ T cells and, together with TGF-, generates IL-9+ IL-10+ Foxp3 effector T cells," Nature Immunology, vol. 9, no. 12, pp. 1347-1355, 2008
114. C. I. Kingsley, M. Karim, A. R. Bushell, and K. J. Wood, "CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4-and IL-10-dependent immunoregulation of alloresponses," Journal of Immunology, vol. 168, no. 3, pp. 1080-1086, 2002
115. M. Miyara and S. Sakaguchi, "Natural regulatory T cells: mechanisms of suppression," Trends inMolecularMedicine, vol. 13, no. 3, pp. 108-116, 2007
116. R. Bacchetta, M. Bigler, J.-L. Touraine et al., "High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells," Journal of Experimental Medicine, vol. 179, no. 2, pp. 493-502, 1994
117. H. Groux, A. O'Garra, M. Bigler et al., "A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis," Nature, vol. 389, no. 6652, pp. 737-742, 1997
118. M. G. Roncarolo, R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings, "Type 1 T regulatory cells," Immunological Reviews, vol. 182, pp. 68-79, 2001
119. F. Gerosa, C. Paganin, D. Peritt et al., "Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon- And interleukin-10," Journal of Experimental Medicine, vol. 183, no. 6, pp. 2559-2569, 1996
120. L. R. Castellano, D. C. Filho, L. Argiro et al., "Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon- production," Human Immunology, vol. 70, no. 6, pp. 383-390, 2009
121. D. Jankovic, M. C. Kullberg, C. G. Feng et al., "Conventional T-bet+Foxp3 Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection," Journal of ExperimentalMedicine, vol. 204, no. 2, pp. 273-283, 2007
122. M. Daheshia, N. Kuklin, S. Kanangat, E. Manickan, and B. T. Rouse, "Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10," The Journal of Immunology, vol. 159, no. 4, pp. 1945-1952, 1997
123. D. R. Nelson, G. Y. Lauwers, J. Y. N. Lau, and G. L. Davis, "Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders," Gastroenterology, vol. 118, no. 4, pp. 655-660, 2000
124. S. Mocellin, F. Marincola, C. R. Rossi, D. Nitti, and M. Lise, "The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle," Cytokine and Growth Factor Reviews, vol. 15, no. 1, pp. 61-76, 2004
125. C. A. Hunter, L. A. Ellis-Neyes, T. Slifer et al., "IL-10 is required to preventimmune hyperactivity during infection with Trypanosoma cruzi," The Journal of Immunology, vol. 158, no. 7, pp. 3311-3316, 1997
126. M. Deckert, S. Soltek, G. Geginat et al., "Endogenous interleukin-10 is required for prevention of a hyperinflammatory intracerebral immune response in Listeria monocytogenes meningoencephalitis," Infection and Immunity, vol. 69, no. 7, pp. 4561-4571, 2001
127. J. Sun, R. Madan, C. L. Karp, and T. J. Braciale, "Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10," Nature Medicine, vol. 15, no. 3, pp. 277-284, 2009
128. R. T. Gazzinelli, M. Wysocka, S. Hieny et al., "In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-, and TNF-," The Journal of Immunology, vol. 157, no. 2, pp. 798-805, 1996
129. Y. Suzuki, A. Sher, G. Yap et al., "IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii," Journal of Immunology, vol. 164, no. 10, pp. 5375-5382, 2000
130. Y. Belkaid, C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks, "CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity," Nature, vol. 420, no. 6915, pp. 502-507, 2002
131. P. J. Murray, L. Wang, C. Onufryk, R. I. Tepper, and R. A. Young, "T cell-derived IL-10 antagonizes macrophage function inmycobacterial infection," Journal of Immunology, vol. 158, no. 1, pp. 315-321, 1997
132. J. F. D. Siawaya, N. Beyers, P. van Helden, and G. Walzl, "Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis," Clinical & Experimental Immunology, vol. 156, no. 1, pp. 69-77, 2009
133. F. Gerosa, C. Nisii, S. Righetti et al., "CD4+ T cell clones producing both interferon- And interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients," Clinical Immunology, vol. 92, no. 3, pp. 224-234, 1999
134. K. W. Moore, R. de Waal Malefyt, R. L. Coffman, and A. O'Garra, "Interleukin-10 and the interleukin-10 receptor," Annual Review of Immunology, vol. 19, pp. 683-765, 2001
135. S. Stäger, A. Maroof, S. Zubairi, S. L. Sanos, M. Kopf, and P. M. Kaye, "Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells," European Journal of Immunology, vol. 36, no. 7, pp. 1764-1771, 2006
136. C. F. Anderson, M. Oukka, V. J. Kuchroo, and D. Sacks, "CD4+CD25Foxp3 Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis," Journal of ExperimentalMedicine, vol. 204, no. 2, pp. 285-297, 2007
137. A. P. F. do Rosário, T. Lamb, P. Spence et al., "IL-27 promotes IL-10 production by effectorTh1CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection,"The Journal of Immunology, vol. 188, no. 3, pp. 1178-1190, 2012
138. D. F. Fiorentino, M. W. Bond, and T. R. Mosmann, "Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production byTh1 clones,"The Journal of Experimental Medicine, vol. 170, no. 6, pp. 2081-20095, 1989
139. S.-H. Im, A. Hueber, S. Monticelli, K.-H. Kang, and A. Rao, "Chromatin-level regulation of the IL10 gene in T cells," The Journal of Biological Chemistry, vol. 279, no. 45, pp. 46818-46825, 2004
140. H. D. Chang, C. Helbig, L. Tykocinski et al., "Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3," European Journal of Immunology, vol. 37, no. 3, pp. 807-817, 2007
141. M. Assenmacher, J. Schmitz, andA. Radbruch, "Flowcytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon- And in interleukin-4-expressing cells," European Journal of Immunology, vol. 24, no. 5, pp. 1097-1101, 1994
142. G. Del Prete, M. De Carli, F. Almerigogna, M. G. Giudizi, R. Biagiotti, and S. Romagnani, "Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production," Journal of Immunology, vol. 150, no. 2,pp. 353-360, 1993
143. A. Roers, L. Siewe, E. Strittmatter et al., "T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation,"The Journal of Experimental Medicine, vol. 200, no. 10, pp. 1289-1297, 2004
144. B. Sawitzki, C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood, "IFN- production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo," Journal of Experimental Medicine, vol. 201, no. 12, pp. 1925-1935, 2005
145. D. Jankovic, D. G. Kugler, and A. Sher, "IL-10 production by CD4+ effector T cells: a mechanism for self-regulation," Mucosal Immunology, vol. 3, no. 3, pp. 239-246, 2010
146. C. Pot, H. Jin, A. Awasthi et al., "Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells," The Journal of Immunology, vol. 183, no. 2, pp. 797-801, 2009
147. R. RodriguesDos Santos Jr., A. Sartori, V. L. Deperon Bonato et al., "Immunemodulation induced by tuberculosisDNAvaccine protects non-obese diabetic mice from diabetes progression," Clinical and Experimental Immunology, vol. 149, no. 3, pp. 570-578, 2007
148. D. Elias, H. Prigozin, N. Polak, M. Rapoport, A. W. Lohse, and I. R. Cohen, "Autoimmune diabetes induced by the -cell toxin STZ: immunity to the 60-kDa heat shock protein and to insulin," Diabetes, vol. 43, no. 8, pp. 992-998, 1994
149. A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, "Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling," Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022-2032, 2006
150. M. Saraiva, J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy, and A. O'Garra, "Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose," Immunity, vol. 31, no. 2, pp. 209-219, 2009
151. M. H. Shaw, G. J. Freeman, M. F. Scott et al., "Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation," Journal of Immunology, vol. 176, no. 12, pp. 7263-7271, 2006
152. R. Spolski andW. J. Leonard, "Interleukin-21: basic biology and implications for cancer and autoimmunity," Annual Review of Immunology, vol. 26, pp. 57-79, 2008
153. R. Spolski, H.-P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard, "IL-21 mediates suppressive effects via its induction of IL-10," Journal of Immunology, vol. 182, no. 5, pp. 2859-2867, 2009
154. W. Cui, Y. Liu, J. S. Weinstein, J. Craft, and S. M. Kaech, "An interleukin-21-interleukin-10-STAT3 pathway is critical for functionalmaturation ofmemory CD8+ T cells," Immunity, vol. 35, no. 5, pp. 792-805, 2011
155. J. A. Olson and S. C. Jameson, "Keeping STATs on memory CD8+ T cells," Immunity, vol. 35, no. 5, pp. 663-665, 2011
156. K. E. Foulds, M. J. Rotte, and R. A. Seder, "IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection," Journal of Immunology, vol. 177, no. 4, pp. 2565-2574, 2006
157. J. C. Cyktor, B. Carruthers, G. L. Beamer, and J. Turner, "Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection," PLoS ONE, vol. 8, no. 3,Article ID e58612, 2013
158. D. Sauma, P. Espejo, A. Ramirez, A. Fierro, M. Rosemblatt, and M. R. Bono, "Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells," Scandinavian Journal of Immunology, vol. 74, no. 1, pp. 62-70, 2011
159. S. Rutz, M. Janke, N. Kassner, T. Hohnstein,M. Krueger, and A. Scheffold, "Notch regulates IL-10 production by T helper 1 cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 9, pp. 3497-3502, 2008
160. F. Auderset, M. Coutaz, and F. Tacchini-Cottier, "The role of notch in the differentiation of CD4+ T helper cells," Current Topics in Microbiology and Immunology, vol. 360, pp. 115-134, 2012
161. C. Helbig, R. Gentek, R. A. Backer et al., "Notch controls the magnitude of T helper cell responses by promoting cellular longevity," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 23, pp. 9041-9046, 2012
162. L. Rivino, P. Gruarin, B. Häringer et al., "CCR6 is expressed on an IL-10-producing, autoreactive memory T cell population with context-dependent regulatory function," Journal of Experimental Medicine, vol. 207, no. 3, pp. 565-577, 2010
163. S. Alas, C. Emmanouilides, and B. Bonavida, "Inhibition of interleukin 10 by Rituximab results in down-regulation of Bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis," Clinical Cancer Research, vol. 7, no. 3, pp. 709-723, 2001
164. Z. S. Boyd, A. Kriatchko, J. Yang, N. Agarwal, M. B. Wax, and R. V. Patil, "Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress," InvestigativeOphthalmology&Visual Science, vol. 44,no. 12, pp. 5206-5211, 2003
165. S. Sieg, C. King, Y. Huang, and D. Kaplan, "The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3," Journal of Virology, vol. 70, no. 7, pp. 4845-4848, 1996
166. K. Taga, J. Chretien, B. Cherney, L. Diaz, M. Brown, and G. Tosato, "Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells," Journal of Clinical Investigation, vol. 94, no. 1, pp. 251-260, 1994
167. S. Poitevin, S. B. H. K. Kechiche, C. Macé, and P. Nguyen, "IL-10 inhibits apoptosis and microvesiculation of humanmonocytes," Journal of Thrombosis and Haemostasis, vol. 7, no. 7, pp. 1241-1243, 2009
168. H. Yang and S.-C. Chen, "The effect of interleukin-10 on apoptosis in macrophages stimulated by oxLDL," European Journal of Pharmacology, vol. 657, no. 1-3, pp. 126-130, 2011
169. S. Dhingra, A. K. Bagchi, A. L. Ludke, A. K. Sharma, and P. K. Singal, "Akt regulates IL-10 mediated suppression of TNF-induced cardiomyocyte apoptosis by upregulating stat3 phosphorylation," PLoS ONE, vol. 6, no. 9, Article ID e25009, 2011
170. J. J. Donnelly, J. B. Ulmer, J. W. Shiver, and M. A. Liu, "DNA vaccines," Annual Review of Immunology, vol. 15, pp. 617-648, 1997
171. J. J. Donnelly, B. Wahren, and M. A. Liu, "DNA vaccines: progress and challenges,"The Journal of Immunology, vol. 175, no. 2, pp. 633-639, 2005
172. V. L. D. Bonato,V. M. F. Lima, R. E. Tascon,D. B. Lowrie, andC. L. Silva, "Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosisinfected mice," Infection and Immunity, vol. 66, no. 1, pp. 169-175, 1998
173. V. L. D. Bonato,E. D. C. Gonçalves, E. G. Soares et al., "Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon- recovery and reduction of lung injury," Immunology, vol. 113, no. 1, pp. 130-138, 2004
174. D. B. Lowrie, R. E. Tascon, V. L. D. Bonato et al., "Therapy of tuberculosis in mice by DNA vaccination," Nature, vol. 400, no. 6741, pp. 269-271, 1999
175. C. L. Silva, V. L. D. Bonato, V. M. F. Lima, L. H. Faccioli, and S. C. Leão, "Characterization of thememory/activated T cells that mediate the long-lived host response against tuberculosis after bacillus Calmette-Guérin or DNA vaccination," Immunology, vol. 97, no. 4, pp. 573-581, 1999
176. W. van Eden, R. van der Zee, and B. Prakken, "Heat-shock proteins induce T-cell regulation of chronic inflammation," Nature Reviews Immunology, vol. 5, no. 4, pp. 318-330, 2005
177. R. R. Santos Junior, A. Sartori, D. S. Lima et al., "DNA vaccine containing the mycobacterial hsp65 gene prevented insulitis in MLD-STZ diabetes," Journal of Immune Based Therapies and Vaccines, vol. 7, article 4, 2009
178. S. F. Zorzella-Pezavento, C. P. Guerino, F. Chiuso-Minicucci et al., "BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis," Clinical and Developmental Immunology, vol. 2013,Article ID 721383, 9 pages, 2013.